Adenosine A(3) receptor suppresses prostate cancer metastasis by inhibiting NADPH oxidase activity.
about
Purinergic signalling and cancerDinosaurs and ancient civilizations: reflections on the treatment of cancerThe anti-tumor effect of A3 adenosine receptors is potentiated by pulsed electromagnetic fields in cultured neural cancer cellsNOX3 NADPH oxidase couples transient receptor potential vanilloid 1 to signal transducer and activator of transcription 1-mediated inflammation and hearing lossShort interfering RNA against STAT1 attenuates cisplatin-induced ototoxicity in the rat by suppressing inflammationAdenosine arrests breast cancer cell motility by A3 receptor stimulation.Molecular mechanisms of A3 adenosine receptor-induced G1 cell cycle arrest and apoptosis in androgen-dependent and independent prostate cancer cell lines: involvement of intrinsic pathway.NOX4 promotes non-small cell lung cancer cell proliferation and metastasis through positive feedback regulation of PI3K/Akt signaling.Resveratrol reduces prostate cancer growth and metastasis by inhibiting the Akt/MicroRNA-21 pathwayNADPH oxidase pathway is involved in aortic contraction induced by A3 adenosine receptor in mice.The interconnectedness of cancer cell signaling.Pharmacological and therapeutic effects of A3 adenosine receptor agonistsA3 adenosine receptor agonist prevents the development of paclitaxel-induced neuropathic pain by modulating spinal glial-restricted redox-dependent signaling pathways.Molecular expression of adenosine receptors in OVCAR-3, Caov-4 and SKOV-3 human ovarian cancer cell linesCF102 an A3 adenosine receptor agonist mediates anti-tumor and anti-inflammatory effects in the liver.Characterization by flow cytometry of fluorescent, selective agonist probes of the A(3) adenosine receptor.Investigational A₃ adenosine receptor targeting agents.Adenosine A1 Receptor Protects Against Cisplatin Ototoxicity by Suppressing the NOX3/STAT1 Inflammatory Pathway in the Cochlea.Modulation of G protein-coupled adenosine receptors by strategically functionalized agonists and antagonists immobilized on gold nanoparticles.Identification of A3 adenosine receptor agonists as novel non-narcotic analgesics.ROS signaling by NADPH oxidase 5 modulates the proliferation and survival of prostate carcinoma cells.The War on Cancer rages on.Adenosine receptors: expression, function and regulation.Adenosine receptor targeting in health and disease.Purinergic signalling in the lower urinary tract.Epigallocatechin-3-gallate, a prototypic chemopreventative agent for protection against cisplatin-based ototoxicity.Apoptosis and cell cycle regulatory effects of adenosine by modulation of GLI-1 and ERK1/2 pathways in CD44+ and CD24- breast cancer stem cells.Extracellular purines, purinergic receptors and tumor growth.Activation of A2b adenosine receptor regulates ovarian cancer cell growth: involvement of Bax/Bcl-2 and caspase-3.Expression of adenosine receptor subclasses in malignant and adjacent normal human prostate tissues.Adenosine and adenosine receptors in the immunopathogenesis and treatment of cancer.A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy.Purinergic Signalling: Therapeutic Developments.Essential role of NADPH oxidase-dependent reactive oxygen species generation in regulating microRNA-21 expression and function in prostate cancer.Multifaceted Effects of Extracellular Adenosine Triphosphate and Adenosine in the Tumor-Host Interaction and Therapeutic Perspectives.A3 Adenosine Receptor Agonist Inhibited Survival of Breast Cancer Stem Cells via GLI-1 and ERK1/2 Pathway.Beyond androgen deprivation: ancillary integrative strategies for targeting the androgen receptor addiction of prostate cancer.
P2860
Q24618782-163CADEC-B5FC-40EC-87E5-1D9FC125543EQ24628746-258C3EEF-5034-48BA-B764-7D4026A7A535Q28728011-3D4DFD2B-DF5B-493B-A255-731AA1404862Q30469563-37A7124A-79FB-4E54-B884-2EB8BA918483Q30473608-DB8EDDBA-22CD-476F-9B14-79018E5860CBQ30829844-D591B452-4350-425D-B729-7E163BB45B7BQ33989019-C5FA76EB-CDCA-45D8-9A8A-810EFEDC91D9Q34100976-D1623854-4149-4BB0-A9BC-D1DB56A93CF5Q34525461-0FD9C236-F437-4221-80BE-EC8072E498BBQ35122894-6F4F74AD-6E56-4F30-B5EC-127EAC57239BQ35669733-80CF6189-5116-4EE3-BCF3-39CF20FC7E5BQ35788500-9DFCA686-95E0-447C-917E-AB1F6DB1BA6DQ35928226-8D341742-0CF2-4B38-A59A-E0427F71ECB5Q36081682-84FB6640-D47E-4AE1-B063-76C88F9A7532Q36327138-DE2BA905-21C4-45F2-975A-0038E835F7D7Q36704325-CADE3469-3EB3-4884-AA6A-A1699D2DBEFDQ36731575-E0097E4A-E584-46E7-ABCD-A53F63AEBACDQ36768399-AA90BCF0-2EC3-4E63-938B-62D96CE7DAD7Q36821548-253590C2-D077-4ED4-9A7F-C203A0A5D49CQ37084901-D1C6523E-87F3-4450-84EF-0C742A34C733Q37105704-8E491E1C-FCB4-46D1-95FF-C0C690E5FEA1Q37478602-D3D7B6FC-64AF-436F-882A-D4BED52A91F5Q37645138-10E8A812-076C-464C-BFA6-5AF810209554Q37948081-C3C0763F-8CDA-43EC-A001-5A029B9DCB7EQ38061933-431B0BF2-CF9D-49C6-8E5E-594D95A2B477Q38681165-3660FCCD-54E4-4401-BE86-9784CB228AD6Q38709195-44F3F9E6-B5C3-4364-86E1-B3894D63E5B6Q38870205-212CB290-7556-4123-888D-4F3EF656E10DQ38886743-848CB6AD-BBE3-4E67-84FC-5771424FBB85Q38907149-A5D3AF71-4F1E-4394-8382-BEDAF0328849Q39148961-C6D5B9A8-6476-4B74-A8A4-F6A811EA7EB7Q39418010-40267235-AA3D-4552-85D6-F317BC11EF0BQ42367885-84CACC13-F7C3-4B77-BCCA-7AF20F2F993DQ42844079-B0B94C24-3736-4AA9-9B3D-32653F8B8D7BQ46026307-44A4BF7C-81C5-4AB5-8712-10C14BB80C8FQ48203969-EDD69B62-3000-4C62-A9FC-9EC38EA135A2Q50455684-E9732E04-D201-4546-965D-E55523D3EDF4
P2860
Adenosine A(3) receptor suppresses prostate cancer metastasis by inhibiting NADPH oxidase activity.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Adenosine A(3) receptor suppre ...... biting NADPH oxidase activity.
@en
type
label
Adenosine A(3) receptor suppre ...... biting NADPH oxidase activity.
@en
prefLabel
Adenosine A(3) receptor suppre ...... biting NADPH oxidase activity.
@en
P2093
P2860
P356
P1433
P1476
Adenosine A(3) receptor suppre ...... biting NADPH oxidase activity.
@en
P2093
Debashree Mukherjea
Kounosuke Watabe
Sarvesh Jajoo
Vickram Ramkumar
P2860
P304
P356
10.1593/NEO.09744
P577
2009-11-01T00:00:00Z